NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older.

Arun J Sanyal Jérémy MagnanensiZouher MajdChristian Rosenquist Delphis M VeraJames P AlmasMargery A Connelly

Published in: Hepatology communications (2023)

The clinical performance of NIS2+™ was superior for the diagnosis of at-risk NASH in patients ≥65 years of age. These data support the clinical value of this blood-based test for the diagnosis of at-risk NASH in older adults.

Keyphrases

end stage renal disease
physical activity
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
electronic health record
machine learning
big data
middle aged